SPRB Latest Press Releases

-- January 18, 2026 --

Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration PRNewswire 7:03 PM

-- January 8, 2026 --

Spruce Biosciences Secures Up to $50 Million in Growth Capital from Avenue Capital Business Wire 8:00 AM

-- December 15, 2025 --

Spruce Biosciences Appoints Proven Pharmaceutical Commercial Leader Keli Walbert to Board of Directors Business Wire 8:00 AM

-- November 10, 2025 --

Spruce Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates Business Wire 4:05 PM

-- October 8, 2025 --

Spruce Biosciences Announces $50.0 Million Private Placement Financing Business Wire 8:00 AM

-- October 6, 2025 --

Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB) Business Wire 8:00 AM

-- September 15, 2025 --

Spruce Biosciences Resumes Trading on the Nasdaq Capital Market Business Wire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software